Pacifica, CA, United States of America

Mike Elias Lizarzaburu

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 10.0

ph-index = 3

Forward Citations = 19(Granted Patents)


Location History:

  • San Bruno, CA (US) (2004 - 2006)
  • San Diego, CA (US) (2009 - 2011)
  • Pacifica, CA (US) (2014 - 2023)

Company Filing History:


Years Active: 2004-2023

Loading Chart...
Loading Chart...
12 patents (USPTO):

Title: Mike Elias Lizarzaburu: Innovator in Creatine Prodrug Technologies

Introduction

Mike Elias Lizarzaburu, based in Pacifica, CA, is a notable inventor recognized for his significant contributions in the field of biochemistry, particularly through his advancements in creatine prodrugs. With a total of 12 patents to his name, Lizarzaburu has made a considerable impact on the treatment of creatine deficiencies.

Latest Patents

Among his latest inventions, Lizarzaburu has developed patent disclosures for "Creatine prodrugs, compositions and methods of use thereof." These innovative creatine prodrug analogs and their compositions are designed specifically for the treatment of creatine deficiencies, underscoring his commitment to addressing healthcare challenges in this area.

Career Highlights

Throughout his career, Lizarzaburu has been affiliated with leading biotech firms, including Amgen Inc. and Ultragenyx Pharmaceutical Inc. His work at these organizations has enabled him to advance his research and apply his inventive ideas in practical applications that significantly benefit patients.

Collaborations

In his journey as an inventor, Lizarzaburu has collaborated with esteemed professionals in the industry, such as Sean P. Brown and Ming Yu. These partnerships have not only fostered innovation but have also contributed to the successful development and implementation of his patented technologies.

Conclusion

Mike Elias Lizarzaburu stands out as a prolific inventor whose work in creatine prodrug technologies is making a tangible difference in healthcare. With his ongoing contributions and collaborations, he continues to inspire innovation in biochemistry and therapeutics, solidifying his role as a key figure in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…